论文部分内容阅读
目的总结羧甲司坦在治疗慢性阻塞性肺疾病的临床疗效。方法 76例慢性阻塞性肺疾病患者随机分成治疗组和对照组,两组均以吸氧、合理抗生素、支气管扩张剂及对症支持治疗,治疗组加用羧甲司坦片(每次0.5g,3次/d,口服),观察两组患者在咳嗽、咳痰、气促、肺部啰音消失时间及平均住院天数的差异。结果治疗组总体疗效优于对照组(P<0.05)。结论羧甲司坦对慢性阻塞性肺疾病具有良好的治疗效果。
Objective To summarize the clinical efficacy of carbocisteine in the treatment of chronic obstructive pulmonary disease. Methods Sixty-six patients with chronic obstructive pulmonary disease were randomly divided into treatment group and control group. Both groups were treated with oxygen inhalation, rational antibiotics, bronchodilators and symptomatic supportive therapy. Patients in treatment group were treated with carbocisteine (0.5g, 3 times / d, orally) to observe the difference between the two groups in cough, sputum, shortness of breath, disappearance of pulmonary rales and average hospitalization days. Results The overall curative effect of the treatment group was better than that of the control group (P <0.05). Conclusion Carbamate has a good therapeutic effect on chronic obstructive pulmonary disease.